Health product recall

Pink Unicorn: Affected lots may contain the undeclared ingredient sildenafil (updated risk classification and reason for recall)

Last updated

Summary

Product
Pink Unicorn
Issue
Health products - Product quality
Health products - Unauthorized product
What to do

Consult your health care professional if you have any health concerns.

Distribution
Quebec

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

Pink Unicorn

Pink Unicorn

Not licensed

Capsule

N/A

All lots

Issue

Affected lots may contain the undeclared ingredient sildenafil.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

7067941 Canada Inc. (D.N.B.)

1264 rue Brodeur, Saint-Paul-d'Abbotsford

Québec, J0E1A0

Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Quebec
Recall class
Type I
Identification number
RA-74105
History
Change log
2023-08-22: Updated risk classification and reason for recall

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe